ADURO BIOTECH, INC. Bonus & Incentive Agreements
12 Contracts & Agreements
- Amended and Restated 2015 Equity Incentive Plan (Filed With SEC on August 7, 2023)
- Retention Bonus Agreement dated January 10, 2020, between the Company and Stephen T. Isaacs (Filed With SEC on March 9, 2020)
- Retention Bonus Agreement dated January 9, 2020, between the Company and Dimitry Nuyten (Filed With SEC on March 9, 2020)
- Retention Bonus Agreement dated January 9, 2020, between the Company and Celeste Ferber (Filed With SEC on March 9, 2020)
- Retention Bonus Agreement dated January 9, 2020, between the Company and Blaine Templeman (Filed With SEC on March 9, 2020)
- ADURO BIOTECH, INC. RESTRICTED STOCK UNIT GRANT NOTICE (2015 EQUITY INCENTIVE PLAN) (Filed With SEC on September 14, 2016)
- ADURO BIOTECH, INC. 2015 EQUITY INCENTIVE PLAN STOCK OPTION GRANT NOTICE (Filed With SEC on April 6, 2015)
- ADURO BIOTECH, INC. 2015 EQUITY INCENTIVE PLAN ADOPTED BY THE BOARD OF DIRECTORS:MARCH 30, 2015 APPROVED BY THE STOCKHOLDERS:APRIL 1, 2015 IPO DATE/EFFECTIVE DATE:[ ], 2015 (Filed With SEC on April 6, 2015)
- NON-QUALIFIED STOCK OPTION AGREEMENT UNDER THE TRITONBIOSYSTEMS, INC. 2001 EQUITY INCENTIVE PLAN (Filed With SEC on March 11, 2015)
- TRITON BIOSYSTEMS, INC. 2001 EQUITY INCENTIVE PLAN (Filed With SEC on March 11, 2015)
- ONCOLOGIC, INC. 2000 LONG-TERM INCENTIVE PLAN SUMMARY OF STOCK OPTION GRANT (Filed With SEC on March 11, 2015)
- ONCOLOGIC, INC. 2000LONG-TERM INCENTIVE PLAN ARTICLE 1. ESTABLISHMENT AND PURPOSE (Filed With SEC on March 11, 2015)
